103577-40-8 | 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole

103577-66-8    134469-07-1    103577-40-8 

[1]ChemicalandPharmaceuticalBulletin,1990,vol.38,p.2853-2858

103577-40-8    138530-94-6    138530-95-7 

[1]CurrentPatentAssignee:TIANJINGREENPINECHINESEMEDICINEPHARMACEUTICAL-CN105218391,2016,ALocationinpatent:Paragraph0177-0184

[2]Thakur,VinayV.;Sudalai[TetrahedronAsymmetry,2003,vol.14,#4,p.407-410]

[3]CurrentPatentAssignee:EMCUREPHARMACEUTICALSLTD.-WO2008/152462,2008,A1Locationinpatent:Page/Pagecolumn18

[4]CurrentPatentAssignee:EMCUREPHARMACEUTICALSLTD.-WO2008/152462,2008,A1Locationinpatent:Page/Pagecolumn19

[5]CurrentPatentAssignee:CODEXISINC-US9228216,2016,B2Locationinpatent:Page/Pagecolumn94-96

[6]Talsi,EvgeniiP.;Bryliakov,KonstantinP.[CatalysisToday,2017,vol.279,p.84-89]

[7]Talsi,EvgeniiP.;Bryliakov,KonstantinP.[CatalysisToday,2017,vol.279,p.84-89]

[8]CurrentPatentAssignee:CHANGZHOUUNIVERSITY-CN111116558,2020,ALocationinpatent:Paragraph0046;0048-0049;0051

103577-40-8    138530-94-6 

[1]Patent:CN106946849,2017,A.Locationinpatent:Paragraph0182-0188;0189-0303

[2]Patent:CN107400119,2017,A.Locationinpatent:Paragraph0026;0027;0032;0034;0044;0048;0052

[3]Patent:CN108314675,2018,A.Locationinpatent:Paragraph0052-0057

[4]ChemistryLetters,2016,vol.45,p.110-112

[5]Patent:CN105218391,2016,A.Locationinpatent:Paragraph0177-0181

[6]OrganicLetters,2007,vol.9,p.2265-2268

[7]Patent:WO2009/117489,2009,A1.Locationinpatent:Page/Pagecolumn57-58

[8]Patent:WO2009/113696,2009,A1.Locationinpatent:Page/Pagecolumn21-22;26

[9]Patent:WO2010/95144,2010,A2.Locationinpatent:Page/Pagecolumn24-25

[10]Patent:WO2011/98938,2011,A1.Locationinpatent:Page/Pagecolumn18

[11]Patent:WO2011/121546,2011,A1.Locationinpatent:Page/Pagecolumn4-5

[12]Patent:US2013/12714,2013,A1.Locationinpatent:Paragraph0073

[13]Patent:WO2013/140120,2013,A1.Locationinpatent:Page/Pagecolumn46-47

[14]Patent:US9145389,2015,B2.Locationinpatent:Page/Pagecolumn8

[15]Patent:CN106565677,2017,A.Locationinpatent:Paragraph0014;0015;0016;0017;0018;0019;0020

[16]Patent:CN106565676,2017,A.Locationinpatent:Paragraph0014;0015;0016;0017;0018;0019;0020

[17]Patent:CN103880819,2017,B.Locationinpatent:Paragraph0020-0123

[18]Patent:CN106518847,2017,A.Locationinpatent:Paragraph0015-0017

[19]Patent:CN106543146,2017,A.Locationinpatent:Paragraph0025;0033;0034;0035;0036;0037;0038

[20]Patent:CN108164507,2018,A.Locationinpatent:Paragraph0018-0023

103577-40-8    99464-83-2   

cyclohexyl1-2-3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethylthio-1H-benzimidazol-1-ylethylcarbonate 

[1]Patent:EP1437352,2004,A1.Locationinpatent:Page27

127337-60-4    583-39-1    103577-40-8 

[1]CurrentPatentAssignee:ITALFARMACOSPA-WO2004/56803,2004,A1Locationinpatent:Page7,8

[2]Locationinpatent:experimentalpartGangula,Srinivas;Elati,ChandrasekharR.;Neredla,Anitha;Baddam,SudhakarR.;Neelam,UdayKumar;Bandichhor,Rakeshwar;Dongamanti,Ashok[OrganicProcessResearchandDevelopment,2010,vol.14,#1,p.229-233]

[3]CurrentPatentAssignee:ZhangDefang;ZhangYi-CN107056753,2017,ALocationinpatent:Paragraph0031;0033

[4]CurrentPatentAssignee:SHANGHAIHUAYUANMEDICINETECHDEV-CN106866630,2017,ALocationinpatent:Paragraph0032;0033;0034;0035;0038

[5]CurrentPatentAssignee:CHANGSHAKANGPULARGEPHARMACY-CN107141280,2017,ALocationinpatent:Paragraph0018;0022;0026

[6]CurrentPatentAssignee:ORCHIDPHARMALTD-WO2011/98938,2011,A1Locationinpatent:Page/Pagecolumn17

[7]CurrentPatentAssignee:ORCHIDPHARMALTD-US2013/12714,2013,A1Locationinpatent:Paragraph0072

[8]CurrentPatentAssignee:HAINANWEIKANGPHARMACEUTICALSQIANSHAN;ZHEJIANGUNIVERSITYOFTECHNOLOGY-CN107011252,2017,ALocationinpatent:Paragraph0115;0116

[9]Locationinpatent:experimentalpartSailu;Ramakrishna;Komaraiah;Reddy[HeterocyclicCommunications,2008,vol.14,#5,p.363-366]

[10]Reddy,GantaMadhusudhan;Mukkanti;Kumar,T.Laxmi;Babu,J.Moses;Reddy,PadiPratap[SyntheticCommunications,2008,vol.38,#20,p.3477-3489]

[11]CurrentPatentAssignee:SYN-TECHCHEM.&PHARM.CO.,LTD.;INDUSTRIALTECHNOLOGYRESEARCHINSTITUTE-US2006/128964,2006,A1Locationinpatent:Page/Pagecolumn3

[12]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP1790647,2007,A1Locationinpatent:Page/Pagecolumn14;15

[13]CurrentPatentAssignee:WOCKHARDTLIMITED-WO2007/138468,2007,A2Locationinpatent:Page/Pagecolumn12

[14]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2010/95144,2010,A2Locationinpatent:Page/Pagecolumn27

[15]Zhou,Zhixu;Li,Linwei;Yan,Ning;Du,Lei;Sun,Changshan;Sun,Tiemin[ChemistryLetters,2016,vol.45,#2,p.110-112]

[16]Ye,Xinyi;Moeljadi,AdhityaMangalaPutra;Chin,KekFoo;Hirao,Hajime;Zong,Lili;Tan,Choon-Hong[AngewandteChemie-InternationalEdition,2016,vol.55,#25,p.7101-7105][Angew.Chem.,2016,vol.128,p.7217-7221]

[17]CurrentPatentAssignee:YOUCAREPHARMACEUTICALGROUPCO.,LTD.-CN106928191,2017,ALocationinpatent:Paragraph0041

[18]CurrentPatentAssignee:LEPUMEDICALTECHNOLOGY(BEIJING)COMPANYLIMITED-CN106946849,2017,ALocationinpatent:Paragraph0177-0181

[19]CurrentPatentAssignee:NANYANGTECHNOLOGICALUNIVERSITY-WO2017/164813,2017,A1Locationinpatent:Page/Pagecolumn29

[20]CurrentPatentAssignee:LIVZONPHARMACEUTICALGROUPINC.-CN113582973,2021,ALocationinpatent:Paragraph0053;0058

Title: 2-{[3-Methyl-4-(2,2,2-trifluoro-eth-oxy)pyridin-2-yl]methyl-sulfan-yl}-1H-benzimidazole monohydrate: a monoclinic polymorph.

Journal: Acta crystallographica. Section E, Structure reports online 20120701

Title: 2-{[3-Methyl-4-(2,2,2-trifluoro-eth-oxy)pyridin-2-yl]methyl-sulfan-yl}-1H-benzimidazole monohydrate.

Journal: Acta crystallographica. Section E, Structure reports online 20110201

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501